Drug Interactions 7.1 Insulin The pharmacokinetic parameters of pramlintide are altered when SYMLIN is mixed in the same syringe with regular, NPH, and 70/30 premixed formulations of recombinant human insulin
Structure & Molecular Data Compound Class & Mechanism PT-141 acts as a selective agonist at MC3R and MC4R melanocortin receptors, with significantly reduced affinity for MC1R compared to Melanotan II
Triple agonists like retatrutide are emerging as next-generation options with potentially different side effect profiles
For example, HMGB1, a DAMP that triggers the inflammasome and promotes the release of pro-inflammatory cytokines including IL-1 and IL-18, can be released by ferroptotic neutrophils
Kessler RC, Birnbaum HG, Shahly V, Bromet E, Hwang I, McLaughlin KA et al (2010)
Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, et al